Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy

Clinical Nephrology

Volumn 63, Issue 1, 2005, Pages 41-45

  Hu, S L ^a   Jaber, B L ^b  

^a BROWN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerular disease; Hepatitis C virus; Interferon treatment; Membranous nephropathy; Ribavirin

Indexed keywords

ALPHA INTERFERON; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISONIAZID; PREDNISONE; RIBAVIRIN;

ADULT; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NEPHROTIC SYNDROME; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; REVIEW; TUBERCULOSIS; URINARY EXCRETION;

EID: 12144284854     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63041     Document Type: Review

References (32)

1. Beddhu S, Bastacky S, Johnson JP 2002 The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine 81: 398-409
2. Bruchfeld A, Lindahl K, Stahle L, Soderberg M. Schvarcz R 2003 Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency Nephrol Dial Transplant 18: 1573-1580
3. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC 2002 Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46: 3317-3326
4. Coroneos E, Petrusevska G, Varghese F, Truong L 1996 Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis 28: 888-892
5. Daghestani L, Pomeroy C 1999 Renal manifestations of hepatitis C infection. Am J Med 106: 347-354
6. Della Rossa A, Tavoni A, Baldini C, Bombardieri S 2002 Treatment of chronic hepatitis C infection with cryoglobulinemia. Curr Opin Rheumatol 14: 231-237
7. DiBisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH 1995 Ribavirin as therapy for chronic hepatitis C. Ann Intern Med 123: 897-903
8. Dimitrov Y, Heibel F, Marcellin L, Chantrel F, Moulin B, Hannedouche T 1997 Acute renal failure and nephrotic syndrome with alpha interferon therapy. Nephrol Dial Transplant 12: 200-203
9. Durand J-M, Cacoub P, Lunel-Fabiani F, Cosserat J, Cretel E, Kaplanski G, Frances C, Bletry O, Soubeyrand J, Godeau P 1998 Ribavirin in hepatitis C-related cryoglobulinemia. J Rheumatol 25: 1115-1117
10. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella P, Pasero G, Bombardieri S 1991 Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 19: 417-420
11. Fried MW, Shiffman ML, Reddy R, Smith C, Marinos G, Gonzales GM, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J 2002 Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982
12. Giannico G, Manno C, Schena FP 2000 Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15: 34-38
13. Guerra G, Narayan G, Rennke H, Jaber B 2003 Crescentic fibrillary glomerulonephritis associated with hepatitis C viral infection. Clin Nephrol 60: 364-368
14. Johnson R, Gretch D, Couser W, Alpers C, Wilson J, Chung M, Hart J, Willson R 1994a Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 46: 1700-1704
15. Johnson R, Willson R, Yamabe H, Couser W, Alpers C, Wener M, Davis C, Gretch D 1994b Renal manifestations of hepatitis C virus infection. Kidney Int 46: 1255-1263
16. Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L 2003 Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. Am J Kidney Dis 42: 184-192
17. Lanford RE, Chavez D, Guerra B, Lau JYN, Hong Z, Brasky KM, Beames B 2001 Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J Virol 75: 8074-8081
18. Lau JYN, Tam RC, Liang TJ, Hong Z 2002 Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology 35: 1002-1009
19. Loustaud-Ratti V, Liozon E, Karaaslan H, Alain S, Paraf F, Le Meur Y, Denis F, Fidal E 2002 Interferon-alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection. Am J Med 113: 516-518
20. Maiza H, MacGregor B, Pouteil-Noble C 1996 De novo glomerulonephritis in renal transplant patients infected by hepatitis C virus and/or hepatitis B virus. J Am Soc Nephrol 7: 1935 (abstract)
21. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK 1998 Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339: 1485-1492
22. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zunetti A 1994 Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330: 751-756
23. Misiani R, Bellavita P, Baio P, Caldara R, Ferruzzi S, Rossi P, Tengattini F 1999 Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-α and ribavirin. Nephrol Dial Transplant 14: 1558-1560
24. Pham H-P, Feray C, Samuel D, Gigou M, Azoulay D, Paradis V, Ducret F, Charpentier B, Debuire B, Lemoine A 1998 Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 54: 1311-1319
25. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C et al 1995 A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604
26. Pouteil-Noble C, Maiza H, Dijoud F, MacGregor B 2000 Glomerular disease associated with hepatitis C virus infection in native kidney disease. Nephrol Dial Transplant 15: 28-33
27. Poynard T, Marcellin P, Lee S, Niederau C, Minuk G, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J 1998 Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352: 1426-1432
28. Quadri R, Giostra E, Roskams T, Pawlotsky J-M, Mentha G, Rubbia-Brandt L, Perrin L, Hadengue A, Negro F 2002 Immunological and virological effects of ribavirin in hepatitis C after liver transplantation. Transplantation 73: 373-378
29. Querenghi F, Yu Q, Billaud G, Maertens G, Trepo C, Zoulim F 2001 Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy. J Viral Hepat 8: 120-131
30. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F 1997 Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25: 1237-1244
31. Zoulim F, Haem J, Ahmed SS, Chossegros P, Habersetzer F, Chevallier M, Bailly F, Trepo C 1998 Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients. J Viral Hepat 5: 193-198
32. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D 2000 Treatment of refractory symptomatic, hepatitis C virus-related mixed cryoglobulinemia with ribavirin and interferon-α. J Rheumatol 27: 2172-2178